Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study - The Lancet Regional Health – Western Pacific
Cells | Free Full-Text | Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex | HTML
Complex structural variations in non-human primate hepatitis B virus | Virology Journal | Full Text
Comparison of hepatitis B virus (HBV) reverse-transcriptase (rt) gene... | Download Scientific Diagram
Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011 - Tanaka - 2018 - Journal of Viral Hepatitis - Wiley Online Library
HBV DNA is a substrate for the cGAS/STING pathway but is not sensed in infected hepatocytes | bioRxiv
Virologic Analysis of Non-B, Non-C Hepatocellular Carcinoma in Japan: Frequent Involvement of Hepatitis B Virus
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes | Scientific Reports
The Oncogenic Role of Hepatitis B Virus | SpringerLink
1) Complete genome sequences of hepatitis B virus revealed mutations affecting hepatocarcinogenesis
Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepat
Detection of Hepatitis B Virus DNA with a Paper Electrochemical Sensor | Analytical Chemistry
The Combination of Nucleotide Analog Therapy and Steroid Pulse Therapy for Acute HBV Infection Effectively Promotes HBV Clearanc
Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of en
IFN-α confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA | Clinical Epigenetics | Full Text
Hepitopes — Experimental Medicine Division
Lamivudine Treatment in Patients with HBV-related Hepatocellular Carcinoma-using an Untreated, Matched Control Cohort
EMA Recommends PreHevbri Hepatitis B Vaccine for Approval - Medical+Health Clúster A.C.
SRC-3 inhibits HBV biosynthesis in HepG2 cells. a-c Knockdown of SRC-3... | Download Scientific Diagram
Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bow
Trouble for GlobeImmune as Gilead exits T Cell activation HBV vaccine
